Rebecca Ryan
Matheson LLPMatheson LLP is a major force in life sciences transactions, including M&A and restructurings, along with healthcare litigation and regulatory matters. It has advised clients on some of the largest life sciences deals of recent years, such as representing Horizon Therapeutics in the proposed $28bn acquisition by Pillartree (a wholly owned subsidiary of Amgen), implemented as an Irish High Court-sanctioned scheme of arrangement. It has defended clients in a series of cases linked to the CervicalCheck scandal, along with other headline healthcare cases. Rebecca Ryan is head of healthcare, specialising in medical negligence and clinical malpractice. Kate McKenna is noted for life sciences regulatory matters and David Fitzgibbon is a leader in life sciences M&A. Emma Doherty is key for corporate governance in both life sciences and healthcare. John Coary was recently promoted to partner.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Rebecca Ryan is exceptional. She offers clear, practical advice, is very responsive and a pleasure to work with.’
‘Large, experienced, professional and highly motivated team, who provide high quality work to agreed timescales and deadlines. Very professional in all communications. Vast knowledge of regulation, statute and case law in relevant area, which informs all advice given, which is always carefully considered and comprehensive in nature.’
‘Very responsive, knowledgeable, approachable. Always willing to go above and beyond in their service and advice. Always clear in the scope of their instructions.’
‘John Coary - efficient, quick, available, understood quickly what we needed.’
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
The lawyer(s) leading their teams.
Rebecca Ryan, Emma Doherty, Kate McKenna